Clinical Trial Update: Testing the Addition of Lenalidomide and Nivolumab to the Usual Treatment for Primary CNS Lymphoma [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the addition of lenalidomide and nivolumab to standard therapy for primary Diffuse Large B-Cell Lymphoma of the Central Nervous Syste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma of the Central Nervous System

Drugs mentioned

• Lenalidomide (lenalidomide)
• nivolumab (nivolumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System | Phase 1 | Status: RECRUITING